Now Know All about Childhood Rhabdomyosarcoma: Cause, Symptoms, Diagnosis, Treatment

Childhood Rhabdomyosarcoma (RMS) is a rare and aggressive cancer that forms in the skeletal muscle tissue. It most commonly affects children under the age of 10, although it can occur in adolescents and adults as well. RMS accounts for approximately 3% of all childhood cancers and can develop anywhere in the body, but it is most frequently found in areas such as the head, neck, bladder, prostate, arms, and legs. Early diagnosis and treatment are critical, and although the disease is rare, advancements in treatment have improved survival rates for many children with this form of cancer. (Source)

Also, read: Now Know All about Childhood Non-Hodgkin Lymphoma: Cause, Symptoms, Diagnosis, Treatment

What is Childhood Rhabdomyosarcoma?

Rhabdomyosarcoma is a type of sarcoma, which refers to cancers that develop in the body’s soft tissues, including muscles, tendons, fat, and bones. Specifically, RMS arises from cells that normally develop into skeletal muscles, the muscles that control voluntary movements. These cancerous cells, called rhabdomyoblasts, grow uncontrollably and form tumors. There are two main subtypes of RMS:

1. Embryonal Rhabdomyosarcoma (ERMS): The most common type, accounting for about 60-70% of cases. It typically affects younger children and is often found in the head, neck, bladder, and reproductive organs.
2. Alveolar Rhabdomyosarcoma (ARMS): A more aggressive subtype, usually seen in older children and adolescents. It typically occurs in the arms, legs, or torso and tends to grow and spread more rapidly. (Source)

Causes of Childhood Rhabdomyosarcoma

The exact cause of rhabdomyosarcoma is not well understood, but researchers believe that it results from genetic mutations in muscle cells that lead to uncontrolled growth. While the specific factors that trigger these mutations are unclear, several potential risk factors have been identified:

• Genetic Conditions: Children with certain inherited conditions such as Li-Fraumeni syndrome, Neurofibromatosis type 1, and Beckwith-Wiedemann syndrome have a higher risk of developing RMS.
• Radiation Exposure: Exposure to radiation, either from environmental sources or previous cancer treatments, may increase the risk.
• Parental Age: Some studies suggest that children born to older parents may have a slightly higher risk of developing RMS.

However, most children with RMS do not have any known risk factors or family history of the disease. (Source)

How Does Childhood Rhabdomyosarcoma Spread?

Rhabdomyosarcoma can spread (metastasize) quickly to other parts of the body. It can invade nearby tissues or spread through the bloodstream and lymphatic system to distant organs. The most common sites of metastasis include:

• Lymph nodes
• Lungs
• Bone marrow
• Bones
• Liver

The rate of spread depends on the subtype of RMS, with alveolar rhabdomyosarcoma tending to spread more rapidly than embryonal rhabdomyosarcoma.

Symptoms of Childhood Rhabdomyosarcoma

The symptoms of RMS can vary depending on the location of the tumor and how advanced it is. Common symptoms include:

• A noticeable lump or swelling: In the arms, legs, or torso, often painless but growing quickly.
• Head and neck tumors: Can cause symptoms like bulging eyes, drooping eyelids, headaches, or nasal congestion.
• Urinary or bowel problems: Tumors in the bladder or reproductive organs can cause painful urination, blood in the urine, or difficulty with bowel movements.
• Difficulty breathing or swallowing: If the tumor is in the chest or throat area.
• Pain: If the tumor is pressing on nearby nerves or organs. (Source)

Diagnosis of Childhood Rhabdomyosarcoma

Diagnosing RMS involves several steps, including medical history, physical examination, and a range of tests to determine the presence, location, and extent of the tumor. Key diagnostic methods include:

1. Imaging Tests:

• X-rays, CT scans, MRI scans: These are used to visualize the tumor and assess its size and location.
• PET scans: Used to detect cancer cells throughout the body.

2. Biopsy:

• A tissue biopsy is essential for confirming the diagnosis. A small sample of the tumor is examined under a microscope to identify cancer cells and determine the type of RMS.

3. Bone Marrow Aspiration and Biopsy:

• Performed to check if the cancer has spread to the bone marrow.

4. Genetic Testing:

• Some forms of RMS, especially alveolar rhabdomyosarcoma, are associated with specific genetic changes that can be identified through tests. (Source)

Treatment of Childhood Rhabdomyosarcoma

Treatment for RMS depends on factors like the tumor’s location, size, spread, and the child’s age and overall health. The primary treatment methods include:

1. Surgery:

• Surgery is used to remove as much of the tumor as possible. In some cases, complete removal may not be feasible, especially if the tumor is near critical organs or structures.

2. Chemotherapy:

• Chemotherapy is a cornerstone of RMS treatment, even after surgery, to kill any remaining cancer cells and prevent the cancer from spreading or recurring. Common chemotherapy drugs used for RMS include vincristine, dactinomycin, and cyclophosphamide.

3. Radiation Therapy:

• Radiation therapy is often used in combination with surgery and chemotherapy to target any remaining cancer cells in areas that are difficult to operate on or where cancer has spread. Radiation is particularly important in cases where the tumor cannot be completely removed by surgery.

Targeted Therapy and Immunotherapy:

• Newer therapies such as targeted drugs and immunotherapy are being explored to treat RMS, especially for children whose cancer has returned after initial treatment. (Source)

Can Childhood Rhabdomyosarcoma Be Prevented?

There is no known way to prevent childhood rhabdomyosarcoma. Most cases occur without any identifiable cause or risk factor, and there are no specific lifestyle or environmental factors that can be modified to reduce the risk. However, genetic counseling may be recommended for families with a history of inherited conditions linked to RMS, such as Li-Fraumeni syndrome. (Source)

Is Childhood Rhabdomyosarcoma Hereditary?

Most cases of RMS are not hereditary and do not run in families. However, a small percentage of cases are associated with genetic syndromes that can be passed down through families. For example:

• Li-Fraumeni Syndrome: Increases the risk of developing RMS and other cancers.
• Neurofibromatosis Type 1: Increases the likelihood of developing soft tissue sarcomas, including RMS.
• Beckwith-Wiedemann Syndrome: Linked to an increased risk of several childhood cancers, including RMS.

Children with these syndromes should be monitored closely for early signs of RMS.

Can Childhood Rhabdomyosarcoma Be Cured?

The prognosis for children with RMS has improved significantly in recent decades due to advancements in treatment. Survival rates depend on several factors, including the type and stage of RMS at diagnosis. Overall, about 70-80% of children with localized rhabdomyosarcoma can be cured, but survival rates are lower if the cancer has spread to distant parts of the body (metastatic RMS).

• Embryonal RMS generally has a better prognosis than Alveolar RMS.
• Children diagnosed with early-stage RMS that has not spread have a higher likelihood of being cured.
• For children with metastatic or recurrent RMS, the prognosis is more challenging, but ongoing research into new treatments, including targeted therapies and immunotherapy, offers hope for improved outcomes. (Source)

Also, watch web stories: 7 Facts You Need to Know about Childhood Leukemia

Conclusion

Childhood Rhabdomyosarcoma is a rare but aggressive cancer that primarily affects the muscles attached to the bones. While its exact cause remains unclear, genetic mutations and certain inherited conditions are known to increase the risk. Early detection, aggressive treatment with surgery, chemotherapy, and radiation, and advances in targeted therapy have significantly improved survival rates. Though not preventable, families with known genetic risks may benefit from genetic counseling and close monitoring. With appropriate treatment, many children with localized RMS can be cured, but challenges remain for those with metastatic or recurrent disease.